G1 Therapeutics (GTHX) Stock Chart & Stock Price History → Trump’s arrest is phase one (From Porter & Company) (Ad) Free GTHX Stock Alerts $3.30 -0.01 (-0.30%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends G1 Therapeutics Stock Price Performance5 Day Performance-19.32%1 Month Performance-12.47%3 Month Performance-0.60%6 Month Performance+75.53%Year-To-Date Performance+8.20%1 Year Performance+29.92% Receive GTHX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for G1 Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyTrump’s arrest is phase oneIn this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now. GTHX Stock Chart for Friday, May, 31, 2024 GTHX Chart by TradingView G1 Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$3.31$3.30-0.30%$3.47$3.25677,035 shs$172.52 million05/30/2024$3.34$3.31-0.90%$3.45$3.24844,924 shs$173.05 million05/29/2024$3.40$3.34-1.76%$3.38$3.221.02 million shs$174.62 million05/28/2024$4.09$3.40-16.87%$4.21$3.072.79 million shs$177.75 million05/27/2024$4.09$4.09$4.34$4.06711,300 shs$213.83 million05/24/2024$4.22$4.09-3.08%$4.33$4.06709,492 shs$213.83 million Get the Latest News and Ratings for GTHX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for G1 Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$4.31$4.22-2.09%$4.33$4.14528,149 shs$220.62 million05/22/2024$4.53$4.31-4.86%$4.76$4.28993,262 shs$225.33 million05/21/2024$4.55$4.53-0.44%$4.74$4.51799,535 shs$236.83 million05/20/2024$4.53$4.55+0.44%$4.72$4.41502,403 shs$237.87 million05/17/2024$4.68$4.53-3.21%$4.69$4.50590,215 shs$236.83 million05/16/2024$4.69$4.68-0.21%$4.76$4.55979,520 shs$244.67 million05/15/2024$4.65$4.69+0.86%$4.92$4.66482,113 shs$245.19 million05/14/2024$4.62$4.65+0.65%$4.83$4.64648,567 shs$243.11 million05/13/2024$4.77$4.62-3.14%$5.00$4.611.55 million shs$241.53 million05/10/2024$4.98$4.77-4.22%$5.15$4.741.39 million shs$249.38 million05/09/2024$4.29$4.98+16.08%$6.14$4.2834.33 million shs$260.36 million05/08/2024$4.25$4.29+0.94%$4.36$4.14559,149 shs$224.28 million05/07/2024$4.27$4.25-0.47%$4.28$4.12361,964 shs$222.19 million05/06/2024$4.49$4.27-4.90%$4.60$4.27498,508 shs$223.24 million05/03/2024$4.44$4.49+1.13%$4.70$4.48574,425 shs$234.87 million05/02/2024$4.13$4.44+7.51%$4.51$4.15730,958 shs$232.26 million05/01/2024$3.77$4.13+9.55%$4.24$3.521.01 million shs$216.04 million04/30/2024$3.72$3.77+1.34%$3.86$3.65528,642 shs$197.21 million04/29/2024$3.99$3.72-6.77%$4.03$3.70690,790 shs$194.31 million04/26/2024$3.86$3.99+3.37%$4.05$3.84441,518 shs$208.40 million04/25/2024$3.99$3.86-3.26%$3.93$3.78538,421 shs$201.61 million04/24/2024$4.19$3.99-4.77%$4.24$3.94343,795 shs$208.40 million04/23/2024$4.10$4.19+2.20%$4.32$4.10354,913 shs$218.84 million04/22/2024$4.11$4.10-0.24%$4.20$3.95487,879 shs$214.14 million04/19/2024$4.17$4.11-1.44%$4.31$3.97733,126 shs$214.67 million04/18/2024$4.28$4.17-2.57%$4.31$4.04687,514 shs$217.80 million04/17/2024$4.08$4.28+4.90%$4.35$4.09690,095 shs$223.54 million04/16/2024$4.31$4.08-5.34%$4.32$4.00568,812 shs$212.98 million04/15/2024$4.55$4.31-5.27%$4.61$4.19669,975 shs$224.98 million04/12/2024$4.68$4.55-2.78%$4.70$4.39563,203 shs$237.51 million04/11/2024$4.65$4.68+0.65%$4.79$4.55479,722 shs$244.29 million04/10/2024$4.88$4.65-4.71%$4.68$4.41982,870 shs$242.73 million04/09/2024$4.77$4.88+2.31%$4.90$4.65679,551 shs$254.74 million04/08/2024$4.78$4.77-0.21%$4.85$4.331.06 million shs$248.99 millionTrump’s arrest is phase one (Ad)In this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now.04/05/2024$4.56$4.78+4.82%$4.83$4.471.04 million shs$249.52 million04/04/2024$4.72$4.56-3.39%$4.83$4.46860,452 shs$238.03 million04/03/2024$4.60$4.72+2.61%$4.82$4.51849,154 shs$246.38 million04/02/2024$4.55$4.60+1.10%$4.67$4.37792,080 shs$240.12 million04/01/2024$4.32$4.55+5.32%$4.64$4.171.01 million shs$237.51 million03/29/2024$4.32$4.32$4.66$4.30956,579 shs$225.50 million03/28/2024$4.47$4.32-3.36%$4.66$4.30936,012 shs$225.50 million03/27/2024$4.29$4.47+4.20%$4.77$4.281.61 million shs$233.33 million03/26/2024$4.14$4.29+3.62%$4.39$4.12832,006 shs$223.94 million03/25/2024$4.00$4.14+3.50%$4.35$3.921.25 million shs$216.11 million03/22/2024$3.70$4.00+8.11%$4.09$3.691.14 million shs$208.80 million03/21/2024$3.45$3.70+7.25%$3.74$3.45989,988 shs$193.14 million03/20/2024$3.28$3.45+5.18%$3.48$3.20889,867 shs$180.09 million03/19/2024$3.21$3.28+2.18%$3.42$3.14672,525 shs$171.22 million03/18/2024$3.11$3.21+3.22%$3.40$2.93815,317 shs$167.56 million03/15/2024$3.12$3.11-0.32%$3.24$3.06440,494 shs$162.34 million03/14/2024$3.46$3.12-9.83%$3.44$3.10548,294 shs$162.86 million03/13/2024$3.32$3.46+4.22%$3.50$3.31492,864 shs$180.61 million03/12/2024$3.48$3.32-4.60%$3.55$3.16822,118 shs$173.30 million03/11/2024$3.64$3.48-4.40%$3.78$3.48390,625 shs$181.66 million03/08/2024$3.58$3.64+1.68%$3.76$3.55446,722 shs$190.01 million03/07/2024$3.53$3.58+1.42%$3.64$3.44737,184 shs$186.88 million03/06/2024$3.54$3.53-0.28%$3.64$3.45607,999 shs$184.27 million03/05/2024$3.66$3.54-3.28%$3.74$3.50730,158 shs$184.79 million03/04/2024$3.73$3.66-1.88%$3.85$3.451.16 million shs$191.05 million03/01/2024$3.32$3.73+12.35%$3.84$3.271.91 million shs$193.36 million02/29/2024$3.33$3.32-0.30%$3.56$3.201.72 million shs$172.11 million Related Companies: RIGL Stock Chart LYEL Stock Chart SLN Stock Chart HROW Stock Chart ALXO Stock Chart DNTH Stock Chart ANAB Stock Chart AVBP Stock Chart ABUS Stock Chart ZYME Stock Chart Receive GTHX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for G1 Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GTHX) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding G1 Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.